{"id":"https://openalex.org/W4411294643","doi":"https://doi.org/10.2337/db25-489-p","title":"489-P: Familial Hypercholesterolemia Is Not Associated with Type 2 Diabetes Presence in Patients Undergoing a Genetic Cascade Screening Program","display_name":"489-P: Familial Hypercholesterolemia Is Not Associated with Type 2 Diabetes Presence in Patients Undergoing a Genetic Cascade Screening Program","publication_year":2025,"publication_date":"2025-06-13","ids":{"openalex":"https://openalex.org/W4411294643","doi":"https://doi.org/10.2337/db25-489-p"},"language":"en","primary_location":{"id":"doi:10.2337/db25-489-p","doi":"https://doi.org/10.2337/db25-489-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db25-489-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007442509","display_name":"Flavia Coimbra Pontes Maia","orcid":"https://orcid.org/0000-0001-8825-757X","observed_orcids":["https://orcid.org/0000-0001-8825-757X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"FL\u00c1VIA C.P. MAIA","raw_affiliation_strings":["S\u00e3o Paulo, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S\u00e3o Paulo, Brazil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083485666","display_name":"Marcio Hiroshi Miname","orcid":"https://orcid.org/0000-0002-4487-5701","observed_orcids":["https://orcid.org/0000-0002-4487-5701"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MARCIO H. MINAME","raw_affiliation_strings":["S\u00e3o Paulo, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S\u00e3o Paulo, Brazil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026654964","display_name":"Kleisson Ant\u00f4nio Pontes Maia","orcid":"https://orcid.org/0009-0007-1770-9306","observed_orcids":["https://orcid.org/0009-0007-1770-9306"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"KLEISSON A.P. MAIA","raw_affiliation_strings":["S\u00e3o Paulo, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S\u00e3o Paulo, Brazil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062180278","display_name":"Hayato Takematsu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"HENRIQUE TAKEMATSU","raw_affiliation_strings":["S\u00e3o Paulo, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S\u00e3o Paulo, Brazil","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"PEDRO G. LORENTE","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"PEDRO G. LORENTE","raw_affiliation_strings":["S\u00e3o Paulo, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S\u00e3o Paulo, Brazil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068799842","display_name":"Marjorie Hayashida Mizuta","orcid":"https://orcid.org/0000-0001-9107-052X","observed_orcids":["https://orcid.org/0000-0001-9107-052X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"MARJORIE H. MIZUTA","raw_affiliation_strings":["S\u00e3o Paulo, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S\u00e3o Paulo, Brazil","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053901502","display_name":"Raul Dias Santos","orcid":"https://orcid.org/0000-0002-9860-6582","observed_orcids":["https://orcid.org/0000-0002-9860-6582"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"RAUL SANTOS","raw_affiliation_strings":["S\u00e3o Paulo, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S\u00e3o Paulo, Brazil","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.21125818,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"74","issue":"Supplement_1","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.9639000296592712,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.03020000085234642,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13430","display_name":"Lipid metabolism and disorders","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/familial-hypercholesterolemia","display_name":"familial hypercholesterolemia","score":0.9959999918937683},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9710000157356262},{"id":"https://openalex.org/keywords/severe-hypercholesterolemia","display_name":"severe hypercholesterolemia","score":0.8550000190734863},{"id":"https://openalex.org/keywords/statin-therapy","display_name":"statin therapy","score":0.8619999885559082},{"id":"https://openalex.org/keywords/beta-cell-apoptosis","display_name":"beta-cell apoptosis","score":0.7369999885559082},{"id":"https://openalex.org/keywords/cardiovascular-disease","display_name":"cardiovascular disease","score":0.5640000104904175},{"id":"https://openalex.org/keywords/diabetes-prevalence","display_name":"diabetes prevalence","score":0.42899999022483826},{"id":"https://openalex.org/keywords/age-as-risk-factor","display_name":"age as risk factor","score":0.6179999709129333},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.3889999985694885}],"concepts":[{"id":"https://openalex.org/C2779120738","wikidata":"https://www.wikidata.org/wiki/Q2711291","display_name":"Familial hypercholesterolemia","level":3,"score":0.8353033065795898},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7198106050491333},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6206550598144531},{"id":"https://openalex.org/C34146451","wikidata":"https://www.wikidata.org/wiki/Q5048094","display_name":"Cascade","level":2,"score":0.5522220730781555},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5008416175842285},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4952143728733063},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3449096083641052},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3426218032836914},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.14782023429870605},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.052857667207717896},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.2337/db25-489-p","doi":"https://doi.org/10.2337/db25-489-p","is_oa":false,"landing_page_url":"https://doi.org/10.2337/db25-489-p","pdf_url":null,"source":{"id":"https://openalex.org/S129060628","display_name":"Diabetes","issn_l":"0012-1797","issn":["0012-1797","1939-327X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320274","host_organization_name":"American Diabetes Association","host_organization_lineage":["https://openalex.org/P4310320274"],"host_organization_lineage_names":["American Diabetes Association"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1561962169","https://openalex.org/W4389956593","https://openalex.org/W4403115981","https://openalex.org/W2736304346","https://openalex.org/W7163612064","https://openalex.org/W2982419790","https://openalex.org/W2069616685","https://openalex.org/W1943660575","https://openalex.org/W2405949882","https://openalex.org/W4313328199"],"abstract_inverted_index":{"Introduction":[0],"and":[1,4,14,35,126,160,253,299,363,369],"Objective:":[2],"Epidemiological":[3],"genetic":[5,53,269],"studies":[6],"have":[7],"shown":[8],"an":[9],"inverse":[10],"association":[11,206,265],"between":[12],"hypercholesterolemia":[13],"type":[15],"2":[16],"diabetes":[17],"(T2DM),":[18],"particularly":[19],"in":[20,25,51,97,192,286],"Familial":[21],"Hypercholesterolemia":[22],"(FH).":[23],"Defects":[24],"LDL":[26],"receptor":[27],"gene":[28],"(LDLR)":[29],"may":[30],"lead":[31],"to":[32,46,178],"beta-cell":[33],"apoptosis,":[34],"statin":[36,175,272],"therapy":[37],"might":[38],"complicate":[39],"it.":[40],"The":[41,184],"study":[42],"evaluated":[43],"biomarkers":[44],"related":[45],"T2DM":[47,71,187,216,281],"severe":[48,64],"hypercholesterolemic":[49,279],"patients":[50,62,89,128,154,182],"a":[52,162],"FH":[54,93,130,153,173,194],"cascade":[55],"screening":[56],"program.":[57],"Methods:":[58],"Cross-sectional":[59],"study,":[60],"1,431":[61],"with":[63,66,90,95,121,215,268,288],"hypercholesterolemia,":[65],"FH-causing":[67],"genes":[68],"or":[69,77,271],"not.":[70],"was":[72,190,266,282],"diagnosed":[73],"by":[74,78],"ADA":[75],"criteria":[76],"the":[79,98,193],"use":[80],"of":[81,87,165,172,180,186,278],"antidiabetic":[82],"medications.":[83],"Results:":[84],"A":[85],"total":[86],"797":[88],"genetically":[91],"confirmed":[92,290],"(96.6%":[94],"variations":[96],"LDLR,":[99],"47.7":[100],"\u00b1":[101,109,117,133,141,146],"15.0":[102],"years;":[103,135],"56.7%":[104],"female;":[105,137],"baseline":[106,138,189],"LDL-C":[107,139],"199":[108],"74":[110],"mg/dL,":[111,143],"body":[112],"mass":[113],"index":[114],"(BMI)":[115],"27.55":[116],"4.85":[118],"kg/m\u00b2,":[119,148],"27.1%":[120],"previous":[122,254],"cardiovascular":[123],"disease,":[124],"(CVD))":[125],"634":[127],"without":[129],"variants":[131],"(56.04":[132],"12.6":[134],"67.4%":[136],"191":[140],"66":[142],"BMI:":[144],"26.91":[145],"5.05":[147],"25.1%":[149],"CVD":[150,255],"were":[151,155],"analyzed.":[152],"younger":[156],"(p<0.001),":[157],"leaner":[158],"(p=0.004),":[159],"had":[161],"higher":[163],"proportion":[164],"males":[166],"(p<":[167],"0.001).":[168,263],"At":[169],"baseline,":[170],"67.8%":[171],"received":[174],"therapy,":[176],"compared":[177],"87.4%":[179],"non-FH":[181],"(p<0.001).":[183],"prevalence":[185],"at":[188],"13.4%":[191],"group":[195,277],"vs.":[196],"21.8%":[197],"(odds":[198],"ratio-OR":[199],"0.555,":[200],"95%CI":[201],"0.420-0.732,":[202],"p<0.001).":[203],"However,":[204],"this":[205,276],"lost":[207],"significance":[208],"after":[209],"multivariate":[210],"analysis.":[211],"Factors":[212],"independently":[213],"associated":[214],"included":[217],"age":[218],"(OR:":[219,228,237,245,256],"1.049,":[220],"95%":[221,230,239,247,258],"CI:":[222,231,240,248,259],"1.032-1.066,":[223],"p":[224,233,250,261],"<":[225,234,251,262],"0.001),":[226,235,243,252],"BMI":[227],"1.111,":[229],"1.073-1.151,":[232],"triglycerides":[236],"1.003,":[238],"1.001-1.005,":[241],"p<":[242],"hypertension":[244],"2.845,":[246],"1.886-4.292,":[249],"1.901,":[257],"1.324-2.729,":[260],"No":[264],"observed":[267],"defects":[270],"therapy.":[273],"Conclusion:":[274],"Among":[275],"individuals,":[280],"not":[283],"less":[284],"prevalent":[285],"those":[287],"molecularly":[289],"FH.":[291],"Disclosure":[292],"F.C.P.":[293],"Maia:":[294,318],"Other":[295],"Relationship;":[296],"Eli":[297,361,367],"Lilly":[298,321,362,368],"Company.":[300,364,370],"Speaker's":[301,309,324,355,365,379,387],"Bureau;":[302,310,325,356,366,380,388],"Amgen":[303,346],"Inc,":[304,347],"Novo":[305,315,326,381],"Nordisk.":[306,316,382],"M.H.":[307,339],"Miname:":[308],"Novartis":[311,328,376,389],"Pharmaceuticals":[312,329,377,390],"Corporation,":[313,330],"Ache,":[314],"K.A.P.":[317],"Research":[319,344,359,371,383],"Support;":[320,345,360,372,384],"USA":[322],"LLC.":[323],"Nordisk,":[327],"Servier":[331],"Laboratories.":[332],"H.":[333],"Takematsu:":[334],"None.":[335,338,341],"P.G.":[336],"Lorente:":[337],"Mizuta:":[340],"R.":[342],"Santos:":[343],"Sanofi.":[348],"Consultant;":[349],"ESPERION":[350],"Therapeutics,":[351],"Inc.,":[352],"Daiichi":[353,357],"Sankyo.":[354,358],"Kowa":[373],"Company,":[374],"Ltd,":[375],"Corporation.":[378,391],"Ionis":[385],"Pharmaceuticals.":[386]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2025-10-10T00:00:00"}